No­var­tis ac­cus­es 2 AveX­is founders of al­ter­ing da­ta, stonewalling probe — but ex-CSO blasts back

No­var­tis has re­spond­ed to the FDA’s ques­tions on the AveX­is da­ta ma­nip­u­la­tion scan­dal, blam­ing two “se­nior” ex­ecs at AveX­is who had helped found the com­pa­ny and re­mained “fix­tures” at the biotech for their role in stonewalling the probe and de­lay­ing their re­sponse. And the phar­ma gi­ant promised that it would ramp up new plans to re­train AveX­is staff and ac­cel­er­ate an in­te­gra­tion plan to the glob­al or­ga­ni­za­tion to make sure it nev­er hap­pened again.

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER